Download - Autonomic sforstudents
![Page 1: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/1.jpg)
AUTONOMIC PHARMACOLOGY
Enrico Ian L. Deliso, MDXU-JPRSM
![Page 2: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/2.jpg)
Autonomic Nervous System (ANS)
• Sympathetic (thoracolumbar) division• Parasympathetic (craniosacral) division
![Page 3: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/3.jpg)
Organization of the ANS
Characteristic Sympathetic Parasympathetic
Origin of preganglionic T1 – T12; L1-L3 CN III, VII, IX, X; S2 – S4
Length of pre-ganglionic axon
Short Long
Neurotransmitter in the Gaglion
ACh ACh
Receptor in ganglion Nicotinic Nicotinic
Length of post-ganglionic axon
Long Short
Neurotransmitter in effector organ
Norepinephrine (except sweat glands-Ach)
Ach
Receptor in effector organs α1,α2,β1,β2,β3 Muscarinic
![Page 4: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/4.jpg)
![Page 5: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/5.jpg)
Enteric Nervous Sytem
• is a large and highly organized collection of neurons located in the walls of the gastrointestinal system
• it is sometimes considered a third division of the ANS• Consist of
– Myenteric plexus (Auerbach)– Submucous Plexus (Meissner)
![Page 6: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/6.jpg)
![Page 7: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/7.jpg)
Uninnervated Receptors
• Respond to autonomic transmitters and drugs but receive no innervation
• Examples:– Muscarinic receptors on endothelium of blood vessels
![Page 8: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/8.jpg)
Cotransmitters
• In the nerve terminals, autonomic nerves has vesicles that contain other transmitter molecules in addition to the main agents
• Involves in the modulation of the synaptic transmission
• Examples:– ATP, enkephalin, VIP
![Page 9: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/9.jpg)
CHOLINERGIC PHARMACOLOGY
![Page 10: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/10.jpg)
Acetylcholine (Ach)
• Primary transmitter in all the automonic ganglia and at the synapses between parasympathetic postganglionic neurons and the effector cells
• Primary transmitter at the somatic system (NMJ)
![Page 11: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/11.jpg)
![Page 12: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/12.jpg)
Cholinergic Drug Effects
• Not very useful, because their effects are not sufficiently selective
• Botulinum toxin, a very large molecule that diffuses slowly, for relatively selective drug effect
![Page 13: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/13.jpg)
Receptor Name
Typical Locations Result of Ligand Binding
Muscarinic
M1
CNS neurons, sympathetic postganglionic neurons, some presynaptic sites
Formation of IP3 and DAG, increased intracellular calcium
Muscarinic
M2
Myocardium, smooth muscle, some
presynaptic sites; CNS neurons
Opening of potassium channels, inhibition of adenylyl cyclase
Muscarinic M3
Exocrine glands, vessels (smooth muscle and endothelium); CNS neurons
Like M1 receptor-ligand binding
Muscarinic
M4
CNS neurons; possibly vagal nerve endings Like M2 receptor-ligand
binding
Muscarinic M5
Vascular endothelium, especially cerebral
vessels; CNS neurons
Like M1 receptor-ligand binding
Nicotinic NN
Postganglionic neurons, some presynaptic cholinergic terminals
Opening of Na+, K+ channels, depolarization
Nicotinic NM
Skeletal muscle neuromuscular endplates Opening of Na+, K+ channels, depolarization
![Page 14: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/14.jpg)
Organ Response
EYES
Sphincter muscle of iris Contraction (miosis)
Ciliary muscle Contraction for near vision
HEART
Sinoatrial node Decrease in rate (negative chronotropy)
Atria Decrease in contractile strength (negative inotropy). Decrease in refractory period
AV node Decrease in conduction velocity (negative dromotropy). Increase in refractory period
Ventricles Small decrease in contractile strength
BLOOD VESSELS
Arteries Dilation (via EDRF). Constriction (high-dose direct effect)
Veins Dilation (via EDRF). Constriction (high-dose direct effect)
![Page 15: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/15.jpg)
LUNG
Bronchial muscle Contraction
Bronchial gland Stimulation
GI
Motility Increase
Sphincters Relaxation
Secretion Stimulation
URINARY BLADDER
Detrussor contraction
Trigone and sphincter relaxation
GLANDS
Sweat, salivary, lacrimal, nasopharyngeal secretion
![Page 16: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/16.jpg)
CHOLINOCEPTOR-ACTIVATING & CHOLINESTERASE-INHIBITING DRUGS
![Page 17: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/17.jpg)
Cholinomimetic Drugs
• Indirect-acting– Edrophomium (short acting)– Carbamates (intermediate to long-acting)– Organophosphates (very long acting)
• Direct-acting– Muscarinic• Choline Esters• Alkaloids
– Nicotinic
![Page 18: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/18.jpg)
DIRECT ACTING CHOLINOMIMETICS
![Page 19: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/19.jpg)
Direct acting Cholinomimetics, MUSCARINIC
DRUG CLINICAL USE TOXICITIESCHOLINE ESTERSAcetylcholine NONE All
parasympathomimetic effects: diarrhea, urinary urgency
Bethanechol Bladder and bowel atony
Pilocarpine Sjogren’s SyndromeGlaucome
ALKALOIDSMuscarine Alkaloid in mushroom Mushroom poisoning
![Page 20: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/20.jpg)
Direct acting Cholinomimetics, NICOTINIC
DRUG CLINICAL USE TOXICITIES
NICOTINE (full Nn agonist) Smoking cessationInsecticide
Generalized ganglionic stimulation: hypertension, tachycardia, nausea, vomiting, diarrheaMAJOR overdose: convulsions, paralysis, coma
VARENICLINE (partial Nn agonist)
Smoking cessation HPN, sweating, sensory disturbance, diarrhea, polyuria, menstrual disturbance
SUCCINYLCHOLINE (selective Nm agonist)
Neuromuscular Relaxation Initial Muscle spasms and postoperative pain
![Page 21: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/21.jpg)
Muscarinic Toxicity
• CNS stimulation• EYE: miosis• LUNGS: bronchoconstriction• GIT/GUT: excessive smooth muscle activity• Increase secretory activity of glands• vasodilation
![Page 22: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/22.jpg)
Reflex compensation for muscarinic toxicity
• Transient bradycardia followed by reflex tachycardia if administered by IV
• Reflex tachycardia for all other routes
![Page 23: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/23.jpg)
Nicotinic Toxicity
• Ganglionic stimulation• Blockade of the Neuromuscular end plate
depolarization – leading to paralysis• CNS toxicity: stimulation (convulsions) followed
by CNS depression
![Page 24: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/24.jpg)
INDIRECT ACTING CHOLINOMIMETICS
![Page 25: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/25.jpg)
MOA of indirect acting cholinomimetics
• Bind to the cholinesterase and undergo prompt hydrolysis
• Amplify Ach effects wherever it is released• No significant actions at uninnervated sites
where Ach is not normally released
![Page 26: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/26.jpg)
Indirect acting cholinomimetics
DRUG CLINICAL USE TOXICITIES
ALCOHOLS
Edrophonium Reversal of nondepolarizing neuromuscular blockade;Diagnosis of Myasthenia; Differentiate myasthenic and cholinergic crisis
Increased parasympathetic effects, nausea, vomiting, diarrhea, urinary urgency
CARBAMATES
Neostigmine Reversal of nondepolarizing neuromuscular blockade;Treatment of MG;Bladder atony
Like edrophonium but longer duration
Pyridostigmine Treatment of MG
Physostigmine Antidote to atropineGlaucoma
Like edrophonium but longer duration plus CNS effects
![Page 27: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/27.jpg)
Myasthenia Gravis
• Autoimmune destruction of nicotinic Ach receptors– Fluctuating muscle weakness– Ocular symptoms– Bulbar symptoms– Proximal muscle weakness
• Myasthenic crisis– Worsening of symptoms– EDROPHONIUM improves muscle strength
• Cholinergic crisis– Excessive activation of cholinoreceptors– EDROPHONIUM weakens muscle strength
![Page 28: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/28.jpg)
Indirect acting cholinomimeticsDRUG CLINICAL USE TOXICITIES
SPECIAL CARBAMATES
RivastigmineGalantamineDonepezilTacrine
Alzheimer’s disease Nausea and Vomiting
ORGANOPHOSPHATES
Parathion Insectecide only Highly Dangerous; ALL parasympathetic effects plus muscle paralysis and coma
Malathion Insecticide and scabicide Safer than parathion
SarinTabun
Nerve gasTerrorist threat
Rapidly lethal
![Page 29: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/29.jpg)
CHOLINORECEPTOR BLOCKERS AND CHOLINESTERASE REGENERATORS
![Page 30: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/30.jpg)
Anticholinergic Drugs
• Antimuscarinic– M1-Selective (Pirenzepine)– Non-selective (Atropine)
• Antinicotinic– Ganglion Blockers (Hexamethomium)– Neuromuscular Blockers (Tubucurarine)
• Cholinesterase regenerators– Oximes (Pralidoxime)
![Page 31: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/31.jpg)
Nonselective Muscarinic AntagonistDrug Clinical Use Toxicities
AtropineCyclopentolateTropicamide
MydriaticCycloplegicAntidote for cholinesterase inhibitor toxicity
All Parasympathetic effects plus sedation, delirium, hyperthermia and flushing
Scopolamine Motion sicknessBenztropineBiperidenTrihexyphenidyl
Anti-ParkinsonismAcute dystonia
IpratropiumTiotropium
COPD
Oxybutynin Urinary UrgencyPostoperative bladder spasms
GlycopyrrolateDicyclomine
AntispasmodicTransient Hypermotility
![Page 32: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/32.jpg)
Selective Muscarinic Antagonist
DRUG CLINICAL USE TOXICITIES
M1 Selective
PirenzepineTelenzepine
PUD Excessive Parasympathetic Effects
M2 Selective
TolterodineDarifenacinFesoterodineSolifenacin
Urinary UrgencyStress incontinence
Excessive Parasympathetic Effects
![Page 33: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/33.jpg)
Contraindications to Muscarinic Blockers
• Infants• Hyperthermia due to decrease sweating• Acute angle closure glaucoma• BPH
![Page 34: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/34.jpg)
Ganglion Blockers
• Competitive pharmacologic antagonists at the nicotinic Ach receptors
• First successful agents for the treatment of HPN but were abandoned because its adverse effects are so severe
![Page 35: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/35.jpg)
Ganglion Blockers
DRUG CLINICAL USE TOXICITIESHexamethonium Hypertension (not
used)Complete blockade of ALL autonomic effects: Postural HypotensionDry mouthBlurred visionConstipationSevere sexual dysfunction
Trimethaphan Hypertensive urgenciesControlled Hypotension
Mecamylamine Smoking cessationTourette’s syndrome
![Page 36: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/36.jpg)
Neuromuscular Blockers
• Important for producing complete skeletal muscle relaxation in surgery
• Classification:– NONDEPOLARIZING (Tubocurarine,
Pancuronium, Atracurium, Vecuronium)– DEPOLARIZING (Succinylcholine)
![Page 37: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/37.jpg)
ADRENERGIC PHARMACOLOGY
![Page 38: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/38.jpg)
Norepinephrine
• Primary transmitter at the sympathetic postganglionic neuron-effector cell synapses in most tissues
• Except:– Sweat glands – Ach
![Page 39: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/39.jpg)
![Page 40: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/40.jpg)
![Page 41: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/41.jpg)
![Page 42: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/42.jpg)
Sites of Autonomic Drug Actions
STEPS INHIBITORS
CHOLINERGIC ADRENERGIC
Synthesis Hemicholinium Metyrosine
Storage Vesamicol Reserpine
Release Botulinum Guanethidine
Termination
Metabolism Neostigmine MAOI’s, COMTIs
Reuptake NONE Cocaine, TCAs
![Page 43: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/43.jpg)
Drug effects on Adrenergic Transmission
• Other drugs promote catecholamine release
• Used in treatment of several diseases (Pheochromocytoma, Hypertension)– Block sympathetic but NOT parasympathetic
functions
![Page 44: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/44.jpg)
SYMPATHOMIMETICS
![Page 45: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/45.jpg)
ADRENERGIC AGONIST• DIRECT ACTING
– ALPHA AGONIST• NONSELECTIVE• ALPHA 1 SELECTIVE• ALPHA 2 SELECTIVE
– BETA AGONIST• NONSELECTIVE• BETA 1 SELECTIVE• BETA 2 SELECTIVE
• INDIRECT ACTING– RELEASERS– REUPTAKE INHIBITORS
![Page 46: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/46.jpg)
MOA OF SYMPATHOMIMETICS
• Direct activation of adrenoceptors• Indirect activation by increasing concentration
of available catecholamines in the synapse– Release of stored catecholamines– Inhibits the reuptake process
![Page 47: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/47.jpg)
Nonselective Direct Acting Catecholamines
DRUG ACTIVITY CLINICAL USE TOXICITIES
Epinephrine α1,α2,β1,β2,β3 AnaphylaxisHemostasis
Excessive sympathomimetic effects: HPN, arrythmia, stroke, MI, pulmonary edema
Norepinephrine α1,α2,β1 Neurogenic ShockLast resort in shock
Extreme vasospasm, tissue necrosis, excessive BP increase, arrythmia and infarction
Dopamine D1, D2α1,α2,β1,β2,β3
Shock, Heart Failure Cardiovascular disturbance, arrythmias
Isoproterenol β1,β2,β3 Acute asthma
![Page 48: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/48.jpg)
Selective α1 Agonist
DRUG CLINICAL USE TOXICITIES
Phenylephrine DecongestantMydriaticNeurogenic Hypotension
HPNStrokeMI
Methoxamine Paroxysmal atrial tachycardia
Midodrine Chronic orthostatic hypotension
![Page 49: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/49.jpg)
Selective α2 Agonist
DRUG CLINICAL USE TOXICITIESClonidine Hypertension Rebound
hypertensionSedation
Methyldopa Pre-eclampsia Hemolyttic AnemiaSedation
ApraclonidineBrimonidine
Glaucoma
![Page 50: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/50.jpg)
Selective β1 Agonist
DRUG CLINICAL USE TOXICITIESDobutamine Heart failure
ShockCardiac stress testing
Tachycardia ArrythmiaTachyphylaxis
![Page 51: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/51.jpg)
Selective β2 Agonist
DRUG CLINICAL USE TOXICITIES
AlbuterolMetaproterenolTerbutaline
Acute BronchospasmAsthma RELIEVER
TachycardiaTremors
SalmeterolFormoterol
Asthma CONTROLLER
Ritodrine Premature Labor
![Page 52: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/52.jpg)
Dopamine
• Low Dose (1-5 mcg/kg/min)– Vasodilation in the splanchnic and renal vascular
beds via D1 receptors
• Medium Dose (5-15 mcg/kg/min)– Increased renal blood flow, hear rate, cardiac
contractility and cardiac output via βreceptors
• High Dose (>15 mcg/kg/min)– Increased BP and vasoconstriction viaαreceptors
![Page 53: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/53.jpg)
Indirect Acting Sympathomimetics
DRUG CLINICAL USE TOXICITIESAmphetamineMethamphetamine
AnorexiantWeight reductionADHDNarcolepsy
AddictionParanoiaAggresionInsomniaArrythmiaHPNConvulsions
Ephedrine NarcolepsyIdiopathic postural hypotensionEnuresis
TachycardiaHypertension
Pseudoephedrine decongestant
![Page 54: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/54.jpg)
Indirect Acting Sympathomimetics
DRUG CLINICAL USE TOXICITIES
Cocaine Local AnestheticIntrinsic Hemostatic Action
AddictionHPNArrythmiasSeizures
Tyramine Found in fermented Foods (cheese)
Hypertensive Crisis when taken together
PhenelzineTranycypromine
Mood Disorders
![Page 55: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/55.jpg)
ADRENORECEPTOR BLOCKERS
![Page 56: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/56.jpg)
Adrenoreceptor Antagonists
• Alpha blockers– Nonselective• Irreversible (Phenoxybenzamine)• Reversible (Phentolamine)
– Alpha 1 selective (Prazosin)– Alpha 2 selective (Yohimbine)
• Beta Blockers– Nonselective (propranolol)– Beta 1 Selective (Atenolol)– Beta 2 Selective (Butoxamine)
![Page 57: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/57.jpg)
Nonselective Alpha Blockers
DRUG CLINICAL USE TOXICITIESPhenoxybenzamine (irreversible and long acting)
Pheochromocytoma, carcinoid, mastocytosis, Raynaud’s phenomenon
Orthostatic Hypotension, Reflex TachycardiaGI irritation
Phentolamine (reversible, short acting)
Pheochromocytoma, antidote to alpha 1 agonist overdose, local vasoconstrictor, rebound HPNED
![Page 58: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/58.jpg)
Selective Alpha 1 Blockers
DRUG CLINICAL USE TOXICITIESPrazosinDoxazosinTerazosin
HPNBPH First Dose orthostatic
Hypotension,Little reflex tachycardia
TamsulosinSilodosin
Urinary HesitancyUrinary RetentionBPH
![Page 59: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/59.jpg)
Selective Alpha 2 Blockers
DRUG CLINICAL USE TOXICITIES
YohimbineRauwolscine
Research applicationED (obsolete)
TachycardiaGI upset
Mirtazapine Depression SomnolenceHypercholesterolemiaIncrease appetite
![Page 60: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/60.jpg)
Nonselective Beta BlockersDRUG CLINICAL USE TOXICITIES
Propranolol AnginaArrythmia HPN, Essential Tremors, Migraine prophylaxis, Variceal Bleeding
Excessive beta blockade:BronchospasmAV blockHeart failure, CNS sedation, masks hypoglycemia in DM patients, ED
Nadolol Longest half life
Pindolol Partial agonist activity
Timolol Galucoma Lacks anesthetic effect
Labetalol Partial agonist activityHPN (pre-ec)Pheochromocytoma
Combined alpha and beta blockade
Carvedilol Heart Failure
![Page 61: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/61.jpg)
Selective Beta 1 BlockersDRUG CLINICAL USE TOXICITIES
Atenolol HPNAnginaArrythmia
Like PropranololLess danger of bronchospasm
Betaxolol Glaucoma
Esmolol Shortest half lifeSVT, Thyrotoxicosis
Acebutolol Partial Agonist activity, SVT
Metoprolol Arrythmia, heart failure
Nebivolol Like atenolol Vasodilation
![Page 62: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/62.jpg)
Selective Beta 2 Blockers
DRUG CLINICAL USE TOXICITIES
Butoxamine Research application
bronchospasm
![Page 63: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/63.jpg)
ORGAN EFFECT
SYMPATHETIC PARASYMPATHETIC
Pupils Mydriasis Miosis
Heart rate Tachycardia Bradycardia
Heart Contractility Increased Decreased
Blood Vessels
Skin, Splanchnic Vasoconstriction No effect
Skeletal Vasodilation No Effect
GI
Motility Decreased Increased
Secretion Decreased Increased
Bladder Relaxation Contraction
Uterus Relaxation (beta 2)Contraction (alpha 1)
Contraction (M3)
Penis Ejaculation erection
![Page 64: Autonomic sforstudents](https://reader034.vdocuments.mx/reader034/viewer/2022052315/554b5914b4c905e9388b4e6f/html5/thumbnails/64.jpg)
ORGAN EFFECT
SYMPATHETIC PARASYMPATHETIC
Sweat glands Increase sweating (Ach)
No effect
Liver GluconeogenesisGlycogenolysis
No effect
Fat cells Lipolysis No effect
Kidney Increase renin release
No effect